These results suggest that although IL-27 activates both STAT1 and STAT3, the regulation and prevention of over-expressing phosphorylated STAT3 requires the presence of activated STAT1 in NSCLC cells. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.